DE69128285T2 - Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung - Google Patents
Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigungInfo
- Publication number
- DE69128285T2 DE69128285T2 DE69128285T DE69128285T DE69128285T2 DE 69128285 T2 DE69128285 T2 DE 69128285T2 DE 69128285 T DE69128285 T DE 69128285T DE 69128285 T DE69128285 T DE 69128285T DE 69128285 T2 DE69128285 T2 DE 69128285T2
- Authority
- DE
- Germany
- Prior art keywords
- clean
- expression
- recombinant polypeptides
- improved possibility
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/564,259 US5202239A (en) | 1990-08-07 | 1990-08-07 | Expression of recombinant polypeptides with improved purification |
PCT/US1991/005617 WO1992002550A1 (en) | 1990-08-07 | 1991-08-07 | Expression of recombinant polypeptides with improved purification |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69128285D1 DE69128285D1 (de) | 1998-01-08 |
DE69128285T2 true DE69128285T2 (de) | 1998-06-25 |
Family
ID=24253763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69128285T Expired - Lifetime DE69128285T2 (de) | 1990-08-07 | 1991-08-07 | Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung |
Country Status (10)
Country | Link |
---|---|
US (2) | US5202239A (de) |
EP (1) | EP0542863B1 (de) |
JP (1) | JP3369168B2 (de) |
AT (1) | ATE160587T1 (de) |
CA (1) | CA2089094C (de) |
DE (1) | DE69128285T2 (de) |
DK (1) | DK0542863T3 (de) |
ES (1) | ES2114539T3 (de) |
GR (1) | GR3026230T3 (de) |
WO (1) | WO1992002550A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
AU6360394A (en) * | 1993-03-03 | 1994-09-26 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
DK144093D0 (de) * | 1993-12-23 | 1993-12-23 | Novo Nordisk As | |
US6764689B1 (en) | 1994-11-10 | 2004-07-20 | Promega Corporation | High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
US6069230A (en) * | 1994-11-10 | 2000-05-30 | Promega Corporation | High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
US5935824A (en) * | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
US5968782A (en) * | 1996-12-04 | 1999-10-19 | Brigham And Womens's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
US5955431A (en) * | 1997-02-05 | 1999-09-21 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
US6077689A (en) * | 1997-12-24 | 2000-06-20 | Amgen Inc. | Enhanced solubility of recombinant proteins |
AU4380599A (en) * | 1998-06-26 | 2000-01-17 | Ppl Therapeutics (Scotland) Limited | Methods for production of recombinant polypeptides |
ATE323765T1 (de) * | 1998-07-10 | 2006-05-15 | Scios Inc | Verfahren zur herstellung eines peptids mit einem pi grösser als 8 oder kleiner als 5 |
US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
US6082594A (en) * | 1998-12-31 | 2000-07-04 | Snowmaker Productions, Inc. | Snowfall simulator with agitating dispenser |
AU5043900A (en) * | 1999-05-24 | 2000-12-12 | Mayo Foundation For Medical Education And Research | Adenovirus vectors encoding brain natriuretic peptide |
US20060160740A1 (en) * | 1999-10-21 | 2006-07-20 | Suad Efendic | Use of GLP-1 or analogs in treatment of stroke |
US6407211B1 (en) | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
EP1276849A4 (de) * | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Albumin fusionsproteine |
US20050100991A1 (en) * | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US6469145B1 (en) * | 2000-06-26 | 2002-10-22 | The United States Of America As Represented By The Secretary Of The Army | One-step purification process for organophosphorus hydrolase enzyme |
US6632638B1 (en) | 2000-11-17 | 2003-10-14 | Amgen, Inc. | Enhanced solubility of recombinant proteins using Uracil DNA glycosylase inhibitor |
WO2002097038A2 (en) * | 2001-05-25 | 2002-12-05 | Human Genome Sciences, Inc. | Chemokine beta-1 fusion proteins |
EP1417237B1 (de) * | 2001-07-26 | 2011-04-06 | Advanced Protein Technologies Corp. | Verfahren zur herstellung von interessanten polypeptiden aus fusionspolypeptiden |
EP2277889B1 (de) | 2001-12-21 | 2014-07-09 | Human Genome Sciences, Inc. | Fusionsproteine von Albumin und Interferon beta |
EP1463752A4 (de) * | 2001-12-21 | 2005-07-13 | Human Genome Sciences Inc | Albuminfusionsproteine |
US20030134352A1 (en) * | 2002-01-04 | 2003-07-17 | Freimuth Paul I. | Facilitating protein folding and solubility by use of peptide extensions |
US7229554B2 (en) * | 2002-09-25 | 2007-06-12 | Novo Nordisk A/S | Purification process comprising microfiltration at elevated temperatures |
AU2003297583B2 (en) | 2002-11-26 | 2010-01-14 | Biocon, Ltd | Modified naturetic compounds, conjugates, and uses thereof |
CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
BRPI0507026A (pt) * | 2004-02-09 | 2007-04-17 | Human Genome Sciences Inc | proteìnas de fusão de albumina |
JP5362349B2 (ja) | 2005-04-15 | 2013-12-11 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | タンパク質を精製する方法 |
US7334279B2 (en) * | 2005-11-09 | 2008-02-26 | Oprandi Arthur V | Mattress pad |
EP2004633A4 (de) | 2006-03-30 | 2009-08-26 | Palatin Technologies Inc | Lineare natriuretische peptidkonstrukte |
US8580746B2 (en) | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
BRPI0709427A2 (pt) | 2006-03-30 | 2011-07-12 | Palatin Technologies Inc | "construto cìclico, composição farmacêutica e uso de um composto |
ES2531372T3 (es) * | 2006-10-13 | 2015-03-13 | Novo Nordisk Healthcare Ag | Enzimas de procesamiento fusionadas a marcadores de proteínas básicas |
WO2012115772A2 (en) | 2011-02-25 | 2012-08-30 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
JP2014525439A (ja) | 2011-08-30 | 2014-09-29 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | ナトリウム利尿ポリペプチド |
EP2750697A4 (de) | 2011-09-02 | 2015-03-25 | Medtronic Inc | Chimäre natriuretische peptidzusammensetzungen und verfahren zu ihrer herstellung |
WO2013103896A1 (en) | 2012-01-06 | 2013-07-11 | Mayo Foundation For Medical Education And Research | Treating cardiovascular or renal diseases |
US9163263B2 (en) | 2012-05-02 | 2015-10-20 | The Goodyear Tire & Rubber Company | Identification of isoprene synthase variants with improved properties for the production of isoprene |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431739A (en) * | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
US4880911A (en) * | 1982-03-19 | 1989-11-14 | G. D. Searle & Co. | Fused polypeptides and methods for their detection |
US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
US4897348A (en) * | 1983-08-25 | 1990-01-30 | Sri International | Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
US4618600A (en) * | 1984-04-19 | 1986-10-21 | Biotechnology Research Associates, J.V. | Novel polypeptide diuretic/vasodilators |
CA1213537A (en) * | 1984-05-01 | 1986-11-04 | Canadian Patents And Development Limited - Societe Canadienne Des Brevets Et D'exploitation Limitee | Polypeptide expression method |
EP0207044A1 (de) * | 1985-06-20 | 1986-12-30 | Monsanto Company | Freisetzung von Peptiden aus Polypeptiden |
GB8518753D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Microbiological products |
US4743679A (en) * | 1986-02-24 | 1988-05-10 | Creative Biomolecules, Inc. | Process for producing human epidermal growth factor and analogs thereof |
DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
-
1990
- 1990-08-07 US US07/564,259 patent/US5202239A/en not_active Expired - Lifetime
-
1991
- 1991-08-07 DK DK91915080T patent/DK0542863T3/da active
- 1991-08-07 JP JP51450991A patent/JP3369168B2/ja not_active Expired - Lifetime
- 1991-08-07 WO PCT/US1991/005617 patent/WO1992002550A1/en active IP Right Grant
- 1991-08-07 CA CA002089094A patent/CA2089094C/en not_active Expired - Lifetime
- 1991-08-07 AT AT91915080T patent/ATE160587T1/de not_active IP Right Cessation
- 1991-08-07 EP EP91915080A patent/EP0542863B1/de not_active Expired - Lifetime
- 1991-08-07 DE DE69128285T patent/DE69128285T2/de not_active Expired - Lifetime
- 1991-08-07 ES ES91915080T patent/ES2114539T3/es not_active Expired - Lifetime
-
1992
- 1992-11-12 US US07/974,932 patent/US5322930A/en not_active Expired - Lifetime
-
1998
- 1998-02-25 GR GR980400410T patent/GR3026230T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69128285D1 (de) | 1998-01-08 |
JP3369168B2 (ja) | 2003-01-20 |
ATE160587T1 (de) | 1997-12-15 |
ES2114539T3 (es) | 1998-06-01 |
DK0542863T3 (da) | 1998-08-10 |
WO1992002550A1 (en) | 1992-02-20 |
CA2089094A1 (en) | 1992-02-08 |
US5322930A (en) | 1994-06-21 |
JPH06504036A (ja) | 1994-05-12 |
GR3026230T3 (en) | 1998-05-29 |
EP0542863A1 (de) | 1993-05-26 |
EP0542863B1 (de) | 1997-11-26 |
EP0542863A4 (en) | 1993-09-22 |
US5202239A (en) | 1993-04-13 |
CA2089094C (en) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69128285D1 (de) | Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung | |
NZ232742A (en) | Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced | |
ATE80660T1 (de) | Verfahren zur herstellung eines polypeptides. | |
KR890010199A (ko) | 활성화된 사람의 단백질 c의 직접 발현용 벡터 및 화합물 | |
ATE297461T1 (de) | Reguliertes autokrines wachstum von säugerzellen | |
ES552234A0 (es) | Un metodo para producir bacterianamente un polipeptido heteralogo que tiene actividad somatotropinica. | |
AR017510A1 (es) | Polinucleotido aislado o recombinante, vector de expresion, celula huesped, metodo para preparar un polipeptido antigenico, metodo y equipo para ladeteccion de un polinucleotido, compuesto de union, metodo de empleo del compuesto de union, polipeptido antigenico aislado o substancialmente puro, ymet | |
EP0196864A3 (de) | Behandlung und Sekretion von rekombinanten Proteinen mittels alkalischer Phosphatase, dazu verwendbare DNA-Sequenzen und mittels dieser Sequenzen transformierte Zellen | |
ATE188994T1 (de) | Methoden zur trans-destabilisierung von spezifischen proteinen in vivo | |
AR012499A1 (es) | Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin | |
WO1995019371A3 (en) | Expression of surface layer proteins | |
WO1999002708A8 (en) | Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein | |
SE8803291D0 (sv) | Recombinant systems for expression of cholera b-subunit with the aid of foreign promoters and/or leader peptides | |
DE3873273D1 (de) | Verfahren zur selektiven spaltung von fusionsproteinen. | |
AU651830B2 (en) | In vitro processing of fusion proteins | |
Kiselev et al. | Structure and function of bacteriorhodopsin. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |